Investigating a new treatment approach for patients with recurrent gout flares and elevated uric acid levels.
This clinical trial is evaluating an investigational medication designed to help patients who experience frequent gout flares despite current treatment. The study aims to determine whether this new approach can reduce the frequency and severity of gout attacks while lowering uric acid levels.
Gout is caused by the buildup of uric acid crystals in joints, leading to sudden, severe episodes of pain, swelling, and redness. For many patients, current medications don't provide adequate relief. This study explores a potentially more effective treatment option.
You may be eligible for this study if you:
Not sure if you qualify? Complete our quick eligibility screening below to find out. It takes less than 2 minutes and is completely confidential.
If you qualify for the study, participation includes:
Qualified participants will receive compensation for their time and travel expenses. All study-related medications, tests, and procedures are provided at no cost to you.
Specific compensation details will be provided during the screening process.
Answer a few quick questions to see if you may qualify for this study. This screening is completely confidential â your answers are processed locally and are not stored or transmitted unless you choose to submit your contact information.
We have several active clinical trials. You may be eligible for more than one.
Evaluating a novel biologic therapy for moderate to severe RA.
Studying a new approach to increasing bone density.